Zobrazeno 1 - 8
of 8
pro vyhledávání: '"RI-XIONG WANG"'
Publikováno v:
Cancer Management and Research
Rixiong Wang,1,2 Hui Liu,3,4 Jun Song,3,4 Qing Wu1,2 1Department of Oncology, the First Affiliated Hospital of Fujian Medical University, Fuzhou City, Peopleâs Republic of China; 2Fujian Key Laboratory of Precision Medicine for Cancer, the First
Autor:
RI-XIONG WANG1, HUI LIU2,3,4,5, LI XU2,3,4,5, HUI ZHANG2,3,4,5, RUI-XIANG ZHOU2,3,4,5 zhourx@mail.fjmu.edu.cn
Publikováno v:
Oncology Letters. Aug2016, Vol. 12 Issue 2, p897-903. 7p.
Publikováno v:
Oncology reports. 42(2)
Transforming growth factor β (TGF‑β) is a polypeptide growth factor with various biological activities, and is widely distributed in various tissues. In mammals, TGF‑β has three isoforms: TGF‑β1, 2, and 3, of which TGF‑β1 is most abundan
Publikováno v:
Oncology Reports. 34:2541-2546
The melatonin nuclear receptor is an orphan member of the nuclear receptor superfamily RZR/ROR, which consists of three subtypes (α, β and γ), suggesting that immunomodulatory and antitumor effects through the intracellular action of melatonin dep
Autor:
Li Li, Sai-Jun Ma, Jian-Hua Luo, Zhi-Guang Zhang, Ri-Xiong Wang, Hui Liu, Hui Zhang, Rui-Xiang Zhou, Jun Song
Publikováno v:
Oncology reports. 39(4)
Globally, gastric cancer (GC) is one of the most common types of cancer and the third leading cause of cancer‑related death. In China, gastric and liver cancers have the highest mortality rates. Melatonin, also known as N-acetyl‑5-methoxytryptami
Publikováno v:
The FASEB Journal. 29
This study aims to explore the relationship between melatonin (MLT) and gastric cancer angiogenesis by nuclear receptor with ELISA, real-time quantitative RT-PCR, IHC, Western blot, and siRNA metho...
Publikováno v:
Anatomical record (Hoboken, N.J. : 2007). 296(6)
Melatonin (MLT) is an indolic hormone produced mainly by the pineal gland. Recent human and animal studies have shown that MLT exerts obvious oncostatic activity both in vitro and in vivo. The purpose of this study was to investigate the antiprolifer
Publikováno v:
Oncology Reports; 2015, Vol. 34 Issue 5, p2541-2546, 6p